Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers
AssigneeNovo Nordisk A/S
InventorBernard Thorens
Life of this patent
Estimating the term…
Abstract
The present invention relates to a recombinant glucagon like peptide-1 (GLP-1), to a DNA construct which comprises a DNA sequence encoding a GLP-1 receptor, to methods of screening for agonists of GLP-1 activity, and to the use of the GLP-1 receptor for screening for agonists of GLP-1 activity.
Claims11
An isolated glucagonlike peptide-1 (GLP-1) receptor polypeptide having the amino acid sequence of a naturally occurring mammalian GLP-1 receptor encoded by a cDNA molecule isolated from a pancreatic islet library and comprising a nucleotide sequence selected from the group consisting of:
- SEQ ID NO:
- 1;
- SEQ ID NO:
- 3;
- and
- the sequence of a cDNA molecule capable of specifically hybridizing with a probe having the sequence of the complement of SEQ ID NO:
- 1 or SEQ ID NO:
- 3 under conditions of relaxed stringency, wherein a probe having the sequence of the complement of SEQ ID NO:
- 1 will specifically identify a cDNA comprising the sequence shown in SEQ ID NO:
- 3 in a human cDNA library,
- said receptor polypeptide capable of binding GLP-1 with a K.sub.D of less than 100 nM.
An isolated DNA molecule comprising the nucleotide sequence shown in SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.